UCB8600
/ UCB
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
September 09, 2021
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Participants, Atopic Participants, and Chronic Spontaneous Urticaria Participants
(clinicaltrials.gov)
- P1; N=40; Terminated; Sponsor: UCB Biopharma SRL; Trial completion date: Jul 2022 ➔ Aug 2021; Active, not recruiting ➔ Terminated; Trial primary completion date: Jul 2022 ➔ Aug 2021; internal company decision; not safety related
Clinical • Trial completion date • Trial primary completion date • Trial termination • Chronic Spontaneous Urticaria • Dermatology • Urticaria
August 05, 2021
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Participants, Atopic Participants, and Chronic Spontaneous Urticaria Participants
(clinicaltrials.gov)
- P1; N=40; Active, not recruiting; Sponsor: UCB Biopharma SRL; Recruiting ➔ Active, not recruiting
Enrollment closed • Chronic Spontaneous Urticaria • Dermatology • Urticaria
July 22, 2021
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Participants, Atopic Participants, and Chronic Spontaneous Urticaria Participants
(clinicaltrials.gov)
- P1; N=174; Recruiting; Sponsor: UCB Biopharma SRL; Trial completion date: Aug 2021 ➔ Jul 2022; Trial primary completion date: Aug 2021 ➔ Jul 2022
Clinical • Trial completion date • Trial primary completion date • Chronic Spontaneous Urticaria • Dermatology • Urticaria
July 22, 2020
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Participants, Atopic Participants, and Chronic Spontaneous Urticaria Participants
(clinicaltrials.gov)
- P1; N=162; Recruiting; Sponsor: UCB Biopharma SRL; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Dermatology • Dermatopathology • Urticaria
June 23, 2020
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Participants, Atopic Participants, and Chronic Spontaneous Urticaria Participants
(clinicaltrials.gov)
- P1; N=162; Not yet recruiting; Sponsor: UCB Biopharma SRL
Clinical • New P1 trial • Dermatology • Dermatopathology • Urticaria
1 to 5
Of
5
Go to page
1